Robert W. Duggan - 30 Jun 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Sandra Gardiner, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
30 Jun 2021
Net transactions value
+$49,999,992
Form type
4
Filing time
02 Jul 2021, 16:48:41 UTC
Previous filing
21 May 2021
Next filing
23 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $49,999,992 +3,048,780 +26% $16.40 14,708,561 30 Jun 2021 Direct F1
holding PLSE Common Stock 330,019 30 Jun 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired pursuant to the terms of that certain purchase agreement by and between the Reporting Person and the Issuer, of which consideration included the satisfaction of a loan from the Reporting Person to the Issuer.
F2 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.